A new device for rapid isolation by size and characterization of rare circulating tumor cells

Anticancer Research

Volumn 31, Issue 2, 2011, Pages 427-441

  Desitter, Isabelle ^a   Guerrouahen, Bella S ^a   Benali Furet, Naoual ^a   Wechsler, Janine ^a   Jänne, Pasi A ^b   Kuang, Yanan ^b   Yanagita, Masahiko ^b   Wang, Lilin ^b   Berkowitz, Jillian A ^b   Distel, Robert J ^b   Cayre, Yvon E ^a,c  

^a ScreenCell   (France)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Cell culture; Circulating tumor cells; CTCs; Cytomorphology; FISH; Lung cancer; Microfiltration by size; Molecular biology; qRT PCR; Real time quantitative reverse transcriptase polymerase chain reaction

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR;

ARTICLE; CELL ISOLATION; CELL SEPARATION; CELL VIABILITY; CONTROLLED STUDY; CYTOLOGY; EXON; FILTER; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MOLECULAR BIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; TUMOR CELL; TUMOR CELL CULTURE; TUMOR VOLUME;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL SEPARATION; CELL SIZE; COLORECTAL NEOPLASMS; CYTOLOGICAL TECHNIQUES; EXONS; FILTRATION; GENE DELETION; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79953251573     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Fehm T, Sagalowsky A, Clifford E, Beitsch P, Saboorian H, Euhus D, Meng S, Morrison L, Tucker T, Lane N, Ghadimi BM, Heselmeyer-Haddad K, Ried T, Rao C and Uhr J: Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 8: 2073-2084, 2002. (Pubitemid 34753576)
2. Racila E, Euhus D, Weiss AJ, Rao C, McConnell J, Terstappen LW and Uhr JW: Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95: 4589-4594, 1998. (Pubitemid 28207957)
3. Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss T J, Ciobanu N, Tallman M S, Kennedy MJ, Davidson NE and Sweet D: Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunohistochemical and clonogenic assay techniques. Blood 82: 2605-2610, 1993. (Pubitemid 23318065)
4. Naume B, Borgen E, Beiske K, Herstad TK, Ravnås G, Renolen A, Trachsel S, Thrane-Steen K, Funderud S and Kvalheim G: Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. J Hematother 6: 103-114, 1997.
5. Hardingham JE, Kotasek D, Farmer B, Butler RN, Mi JX, Sage RE and Dobrovic A: Immunobead-PCR: a technique for the detection of circulating tumor cells using immunomagnetic beads and the polymerase chain reaction. Cancer Res 53: 3455-3458, 1993. (Pubitemid 23229617)
6. Zigeuner RE, Riesenberg R, Pohla H, Hofstetter A and Oberneder R: Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. J Urol 164: 1834-1837, 2000.
7. Bilkenroth U, Taubert H, Riemann D, Rebmann U, Heynemann H and Meye A: Detection and enrichment of disseminated renal carcinoma cells from peripheral blood by immunomagnetic cell separation. Int J Cancer 92: 577-582, 2001. (Pubitemid 32319433)
8. Kagan M, Howard D, Bendele T, Mayes J, Silvia J, Repollet M, Doyle J, Allard J, Tu N, Bui T, Russell T, Rao C, Hermann M, Rutner H and Terstappen LWMM: A sample preparation and analysis system for identification of circulating tumor cells. J Clin Ligand Assay 25: 104-110, 2002. (Pubitemid 34984736)
9. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AGJ, Uhr JW and Terstappen LWMM: Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10: 6897-6904, 2004. (Pubitemid 39383039)
10. Müller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Jänicke F and Pantel K: Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res 11: 3678-3685, 2005. (Pubitemid 40685584)
11. Wu CH, Lin SR, Yu FJ, Wu DC, Pan YS, Hsieh JS, Huang SY and Wang JY: Development of a high-throughput membrane-array method for molecular diagnosis of circulating tumor cells in patients with gastric cancers. Int J Cancer 119: 373-379, 2006.
12. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M and Haber DA: Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359: 366-377, 2008.
13. Fehm T, Hoffmann O, Aktas B, Becker S, Solomayer EF, Wallwiener D, Kimmig R and Kasimir-Bauer S: Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Research 11: 109, 2009.
14. Zabaglo L, Ormerod MG, Parton M, Ring A, Smith IE and Dowsett M: Cell filtration-laser scanning cytometry for the characterisation of circulating breast cancer cells. Cytometry Part A 55: 102-108, 2003. (Pubitemid 37522512)
15. Hosokawa M, Hayata T, Fukuda Y, Arakaki A, Yoshino T, Tanaka T and Matsunaga T: Size-selective microcavity array for rapid and efficient detection of circulating tumor cells. Anal Chem 82: 6629-6635, 2010.
16. Vona G, Sabile A, Louha M, Sitruck V, Romana S, Schütze K, Capron, Franco D, Pazzagli M, Vekemans M, Lacour B, Bréchot C and Paterlini-Bréchot P: Isolation by size of epithelial tumor cells: a new method for the immunopharmological and molecular characterization of circulating tumor cells. Am J Pathol 156: 57-63, 2000.
17. Braun S and Marth C: Circulating tumor cells in metastatic breast cancer - Toward individualized treatment? N Engl J Med 351: 824-826, 2004.
18. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW and Hayes DF: Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351: 781-791, 2004.
19. Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, Fritsche HA, Hortobagyi GN and Terstappen LW: Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J Clin Oncol 23: 1420-1430, 2005. [Erratum, J Clin Oncol 23:4808, 2005.]
20. Krivacic RT, Ladanyi A, Curry DN, Hsieh HB, Kuhn P, Bergsrud DE, Kepros JF, Barbera T, Ho MY, Chen LB, Lerner RA and Bruce RH: A rare-cell detector for cancer. Proc Natl Acad Sci USA 101: 10501-10504, 2004. (Pubitemid 38955770)
21. Steinarsdottir M, Jónasson JG, Vi arson H, Júlí usdóttir H, Hauksdóttir H and Ögmundsdóttir HM: Cytogenetic changes in nonmalignant breast tissue. Genes Chromosomes and Cancer 41: 47-55, 2004.
22. Sheu CC, Yu YP, Tsai JR, Chang MY, Lin SR, Hwang JJ and Chong IW: Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer. Int J Cancer 119: 1419-1426, 2006.
23. Tibbe AG, Miller J, M Craig M and Terstappen LWMM: Statistical considerations for enumeration of circulating tumor cells. Cytometry A 71: 154-162, 2007. (Pubitemid 46355340)
24. Sieuwerts AM, Kraan J, Bolt J, van der Spoel P, Elstrodt F, Schutte M, Martens JWM, Gratama J-W, Sleijfer S and Foekens JA: Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells. J Natl Cancer Inst 101: 61-66, 2009.
25. Mego M, Mego M, Megà M, Mani S, Li C, Andreoupolou E, Tin S, Jackson S, Cohen E, Gao H, Cristofanilli M and Reuben J: Circulating tumor cells (CTCs) and epithelial-mesenchymal transition (EMT) in breast cancer: Describing the heterogeneity of microscopic disease. Cancer Res 69 (Meeting Abstract Supplement), 3011, December 15, 2009.
26. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
27. Visvader JE and Lindeman GJ: Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 8: 755-768, 2008.
28. James Bean J , Brennan C, Shih J-Y, Riely G, Viale A, Wang L, Chitale D, Motoi N, Szoke J, Broderick S, Balak M, Chang W-C, Yu C-J, Gazdar A, Pass H, Rusch V, Gerald W, Huang S-F, Yang P-C, Miller V, Ladanyi M, Yang C-H and Pao W: MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib. Proc Natl Acad Sci USA 104: 20932-20937, 2007.
29. De Giorgi V, Pinzani P, Salvianti F, Panelos J, Paglierani M, Janowska A, Grazzini M, Wechsler J, Orlando C, Santucci M, Lotti T, Pazzagli M and Massi D: Application of a filtration-and isolation-by-size technique for the detection of circulating tumor cells in cutaneous melanoma. J Invest Dermato 130: 2440-2447, 2010.
30. Cristofanilli M, Broglio KR, Guarneri V, Jackson S, Fritsche HA, Islam R, Dawood S, Reuben JM, Kau SW, Lara JM, Krishnamurthy S, Ueno NT, Hortobagyi GN and Valero V: Circulating tumor cells in metastatic breast cancer: biologic staging beyond tumor burden. Clin Breast Cancer 7: 471-479, 2007. (Pubitemid 46424284)
31. Demel U, Tilz GP, Foeldes-Papp Z, Gutierrez B, Albert WH and Böcher O: Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay. J Exp Clin Cancer Res 23: 465-468, 2004. (Pubitemid 39490631)
32. Zieglschmid V, Hollmann C, Gutierrez B, Albert W, Strothoff D, Gross E and Bocher O: Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells. Anticancer Res 25: 1803-1810, 2005.
33. Lankiewicz S, Gutierrez B, Rivero B and Böcher O: Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment. Mol Biotechnol 34: 15-28, 2006.
34. Maheswaran S, Sequist LV, Nagrath S, Ulkus L, Brannigan B, Collura CV, Inserra E, Diederichs S, Iafrate AJ, Bell DW, Digumarthy S, Muzikansky A, Irimia D, Settleman J, Tompkins RG, Lynch TJ, Toner M and Haber DA: Detection of mutations in EGFR in Circulating Lung Cancer Cells. N Engl J Med 359: 366-377, 2008.
35. Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA and Toner M: Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450: 1235-1239, 2007.
36. Stott SL, Hsu CH, Tsukrov DI, Yu M, Miyamoto DT, Waltman BA, Rothenberg SM, Shah AM, Smas ME, Korir GK, Floyd FP Jr,Gilman AJ, Lord JB, Winokur D, Springer S, Irimia D, Nagrath S, Sequist LV, Lee RJ, Isselbacher KJ, Maheswaran S, Haber DA and Toner M: Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA 107: 18392-18397, 2010.
37. Yen LC, Yeh YS, Chen CW, Wang HM, Tsai HL, Lu CY, Chang YT, Chu KS, Lin SR and Wang JY: Detection of KRAS oncogene in peripheral blood as a predictor of the response to cetuximab plus chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res 15: 4508-4513, 2009.
38. Lièvre A, Bachet JB, Le Corre D, Boige V, Landi B, Emile JF, Côté JF, Tomasic G, Penna C, Ducreux M, Rougier P, Penault-Llorca F and Laurent-Puig P: KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. Cancer Res 66: 3992-3995, 2006.
39. Andreopoulou E, Urbauer DL, Krishnamurthy S, Reuben JM, Valero V, Cristofanilli M and Fritsche H: Comparison of circulating tumor cells (CTCs) in metastatic breast cancer (MBC): AdnaTest breast cancer for detection and biological characterization. AACR Meeting Abstracts 2008: A6, 2008.
40. Dirix LY, Elst H, Benoy I, Auw I Van der, Prové A, Wuyts H, Maes H, van Dam P, Huget P, Vermeulen P and Sint-Augustinus AZ: Circulating tumor cell detection: a direct comparison between the CellSearch system, the AdnaTest, and CK-19/mammaglobin RT-PCR in patients with metastatic breast cancer [abstract]. J Clin Oncol 27(Suppl): e22117, 2009.